PharmaPoint: Hepatitis C Virus – Current and Future Players
Table Of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 9
2.3 Upcoming Related Reports 11
3 Market Outlook 12
3.1 Global Markets 12
3.1.1 Forecast 12
3.1.2 Drivers and Barriers – Global Issues 16
4 Current and Future Players 21
4.1 Overview 21
4.2 Trends in Corporate Strategy 23
4.3 Company Profiles 24
4.3.1 Merck 24
4.3.2 Roche 26
4.3.3 Vertex 28
4.3.4 Janssen 29
4.3.5 Gilead 31
4.3.6 AbbVie 34
4.3.7 Bristol-Myers Squibb 36
4.3.8 Boehringer Ingelheim 38
4.4 Additional Companies with Promising Drugs 40
4.4.1 Mitsubishi Tanabe 40
4.4.2 GlaxoSmithKline 41
4.4.3 Achillion 41
4.4.4 Scynexis 42
4.4.5 Idenix 43
4.4.6 Presidio 44
5 Appendix 45
5.1 Bibliography 45
5.2 Abbreviations 48
5.3 Methodology 49
5.4 Forecasting Methodology 49
5.4.1 Percent Drug-Treated Patients 49
5.4.2 Patient Warehousing 50
5.4.3 Drugs Included in Each Therapeutic Class 50
5.4.4 Launch and Patent Expiry Dates 51
5.4.5 General Pricing Assumptions 52
5.4.6 Individual Drug Assumptions 52
5.4.7 Generic Erosion 55
5.4.8 Selection of Pipeline Agents 55
5.4.9 Pricing of Pipeline Agents 56
5.5 Physicians and Specialists Included in this Study 59
5.6 Survey of Prescribing Physicians 61
5.7 About the Authors 62
5.7.1 Author 62
5.7.2 Epidemiologist 62
5.7.3 Global Head of Healthcare 63
5.8 About GlobalData 64
5.9 Contact Us 64
5.10 Disclaimer 64
List Of Tables
Table 1: Global Sales Forecasts ($m) for HCV, 2012–2022 14
Table 2: HCV Market – Drivers and Barriers, 2013 16
Table 3: Key Companies in the HCV Market, 2012 22
Table 4: Merck’s HCV Portfolio Assessment, 2012 25
Table 5: Merck SWOT Analysis, 2012 25
Table 6: Roche’s HCV Portfolio Assessment, 2012 27
Table 7: Roche SWOT Analysis, 2012 27
Table 8: Vertex’s HCV Portfolio Assessment, 2012 28
Table 9: Vertex SWOT Analysis, 2012 29
Table 10: Janssen’s HCV Portfolio Assessment, 2012 30
Table 11: Janssen SWOT Analysis, 2012 31
Table 12: Gilead’s HCV Portfolio Assessment, 2012 33
Table 13: Gilead SWOT Analysis, 2012 33
Table 14: AbbVie’s HCV Portfolio Assessment, 2012 35
Table 15: AbbVie SWOT Analysis, 2012 35
Table 16: Bristol-Myers Squibb’s HCV Portfolio Assessment, 2012 37
Table 17: Bristol-Myers Squibb SWOT Analysis, 2012 37
Table 18: Boehringer Ingelheim’s HCV Portfolio Assessment, 2012 39
Table 19: Boehringer Ingelheim SWOT Analysis, 2012 39
Table 20: Mitsubishi Tanabe’s HCV Portfolio Assessment, 2012 40
Table 21: GlaxoSmithKline’s HCV Portfolio Assessment, 2012 41
Table 22: Achillion’s HCV Portfolio Assessment, 2012 42
Table 23: Scynexis’ HCV Portfolio Assessment, 2012 42
Table 24: Idenix’s HCV Portfolio Assessment, 2012 43
Table 25: Presidio’s HCV Portfolio Assessment, 2012 44
Table 26: Key Launch Dates 51
Table 27: Key Patent Expiries 51
Table 28: Physicians Surveyed, By Country 61
List of Figures
Figure 1: Global Sales for HCV Therapeutics by Region, 2012–2022 15
Figure 2: Company Portfolio Gap Analysis in HCV, 2012–2022 22
2014 Deep Research Report on Global and China Naltrexone HCL Industry
Published: 28-Oct-2014 Price: US $2200 Onwards Pages: 138
This is a professional and depth research report on Global Naltrexone HCL industry. The report firstly introduced Naltrexone HCL basic information included Naltrexone HCL definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis. Global Regional (such as US Europe Asia China Japan etc regions) Global Leading Suppliers, different type products, different applications etc Naltrexone HCL production and market shar......
Insulin Market in China 2014-2018
Published: 22-Oct-2014 Price: US $2500 Onwards Pages: 78
Insulin is a hormone produced in the pancreas. It regulates the metabolism of glucose and other nutrients in the body. Insulin permits the body to utilize sugar (glucose) from carbohydrates in the food for energy or to store glucose for future use. Various types of insulin exist depending on how quickly they work, when they peak, and how long they last. In diabetic condition, the pancreas no longer produces adequate insulin or the cells stop responding to the insulin that is produced, leading to......
Global ADHD Drugs Market 2014-2018
Published: 22-Oct-2014 Price: US $2500 Onwards Pages: 80
ADHD is a psychiatric disorder, which is mostly found in children. However, adults have also been reported to be diagnosed with ADHD. The patients with ADHD suffer from several problems including hyperactivity, impulsiveness, and lack of focus and concentration. The causes of ADHD are not known. It is believed to be linked with genetic and environmental causes. However, it has been reported to be related with the decrease in the extraneuronal levels of norepinephrine and dopamine. In addition, t......
Global Huntington’s Disease Therapeutics Market 2014-2018
Published: 22-Oct-2014 Price: US $2500 Onwards Pages: 72
Huntington's disease is a progressive neurodegenerative disorder that can be inherited from one generation to another as an autosomal dominant trait. It arises due to genetically programmed degeneration of neurons in some parts of the brain such as basal ganglia and cerebral cortex. Basal ganglia plays an important role in coordinating movement while cerebral cortex regulates perception, thought, and memory. Degeneration of neurons leads to progressive cognitive impairment and dementia. People w......
Global Pediatric Vaccine Market 2014-2018
Published: 22-Oct-2014 Price: US $2500 Onwards Pages: 85
Pediatric vaccines are used for the immunization of children and adolescents against various infectious diseases, such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases. According to the US FDA, pediatric age ranges are classified as newborn, infant, child, and adolescent, ranging from birth to 21 years. However, the EMA classifies pediatric age range from birth to 18 years.
TechNavio's analysts forecast the Global Pediatric Vaccine market to grow at a CAG......
Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 – New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries
Published: 1-Oct-2014 Price: US $4995 Onwards
GBI Research, the leading business intelligence provider, has released its latest research, ‘Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries’, which provides insights into Major Depressive Disorder (MDD) in the major developed markets of the US, the UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an estimation of market size for 2013, along with market fo......
Penicillin Markets in China
Published: 1-Oct-2014 Price: US $4000 Onwards Pages: 190
China's demand for Penicillin has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry......
Global H1N1 Vaccines Market 2014-2018
Published: 1-Oct-2014 Price: US $2500 Onwards Pages: 66
H1N1 influenza (zoonotic) is an infectious disease in humans caused by a variant of the swine H1N1 virus, known as H1N1v virus. The H1N1v virus is a contagious virus which infects nose, throat, and lungs. H1N1 virus is an RNA virus belonging to the Orthomyxoviridae family. Influenza A viruses infect different animal species such as humans, swine, birds, seals, and horses. Influenza A viruses can be subdivided on the basis of antigenicity of its surface glycoproteins neuraminidase and hemagglutin......
PharmaPoint: HER2-Positive Breast Cancer – US Drug Forecast and Market Analysis to 2023
Published: 30-Sep-2014 Price: US $4995 Onwards Pages: 165
HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage of multiple settings of the disease including neoadjuvant, adjuvant, first-, second-, third-, and fourth-line metastatic.
The high incidence of HER2-positive breast cancer in the US, almost equaling that......
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details - [email protected]
/ +1 888 391 5441 )
- Ad Hoc
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs